REVANCE THERAPEUTICS INC

CUSIP: 761330AB5 Class: NOTE 1.750% 2/1

Bank of New York Mellon Corp's Holding History (CIK: 0001390777)

Note: Option positions (PUT/CALL) are excluded.

Q3 2023
Shares 200,000 Value ($000) $162 Avg Close Range
Q2 2023
Shares 200,000 Value ($000) $212 Avg Close Range
Q1 2023
Shares 200,000 Value ($000) $246 Avg Close Range
Q4 2022
Shares 100,000 Value ($000) $100 Avg Close Range
Q3 2022
Shares 300,000 Value ($000) $314 Avg Close Range